PMID: 11915863Mar 28, 2002Paper

Voluntary health insurance in the European Union: a critical assessment

International Journal of Health Services : Planning, Administration, Evaluation
Elias Mossialos, Sarah M S Thomson

Abstract

The authors examine the role and nature of the market for voluntary health insurance in the European Union and review the impact of public policy, at both the national and E.U. levels, on the development of this market in recent years. The conceptual framework, based on a model of industrial analysis, allows a wide range of policy questions regarding market structure, conduct, and performance. By analyzing these three aspects of the market for voluntary health insurance, the authors are also able to raise questions about the equity and efficiency of voluntary health insurance as a means of funding health care in the European Union. The analysis suggests that the market for voluntary health insurance in the European Union suffers from significant information failures that seriously limit its potential for competition or efficiency and also reduce equity. Substantial deregulation of the E.U. market for voluntary health insurance has stripped regulatory bodies of their power to protect consumers and poses interesting challenges for national regulators, particularly if the market is to expand in the future. In a deregulated environment, it is questionable whether this method of funding health care will encourage a more efficient an...Continue Reading

References

Jan 1, 1992·Health Affairs·M L Barer, R G Evans
May 2, 1991·The New England Journal of Medicine·S Woolhandler, D U Himmelstein
Aug 26, 1995·BMJ : British Medical Journal·A Murdoch
Dec 1, 1993·Journal of Epidemiology and Community Health·M Roland
Mar 13, 1997·The New England Journal of Medicine·S Woolhandler, D U Himmelstein
Mar 1, 1997·Health Affairs·D R Meyer
May 21, 1998·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·C L Rossetto, J Fair
Mar 26, 1999·Health Affairs·M OlfsonH J Schlesinger
Mar 26, 1999·Health Affairs·J Sheils, P Hogan
Apr 8, 1995·Journal of Health Economics·M S Marquis, S H Long
Jul 31, 1999·Disease Markers·UNKNOWN Health Departments of the United Kingdom
Oct 28, 1999·Journal of Health Economics·A WagstaffO Winkelhake
Oct 28, 1999·Journal of Health Economics·E van DoorslaerO Winkelhake
Nov 2, 1999·Health Economics·A M Vera-Hernández
Nov 5, 1999·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·J M BorràsR Vicente
Jan 25, 2000·Health Affairs·M S Marquis, S H Long
Jan 29, 2000·Health Affairs·U E Reinhardt
Mar 9, 2000·International Journal of Health Services : Planning, Administration, Evaluation·E Baris, K McLeod
Mar 16, 2000·Health Affairs·M A Hall
Apr 14, 2000·American Journal of Respiratory and Critical Care Medicine·M R Pinsky, P Rico
Apr 29, 2000·Intensive Care Medicine·M Emmerson
Jun 14, 2000·BMJ : British Medical Journal·D Payne
Aug 5, 2000·Health Affairs·K PollitzJ Specht
Aug 22, 2000·Archives of Disease in Childhood·L RajmilA Segura
Sep 1, 2000·BMJ : British Medical Journal·Y Doyle, A Bull
Nov 15, 2000·Lancet·V Navarro
Jan 5, 2001·Expert Opinion on Investigational Drugs·D R Richardson
Feb 24, 2001·The International Journal of Health Planning and Management·J Puig-Junoy
Mar 10, 2001·Journal of the Royal Society of Medicine·A MurthyE Mossialos

❮ Previous
Next ❯

Citations

Dec 21, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Hans Maarse, Yvette Bartholomée
Jul 28, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Daniëlle M I D Duijmelinck, Wynand P M M van de Ven
Sep 16, 2008·BMC Health Services Research·Enrique RegidorVicente Domínguez
Sep 15, 2005·Health Economics·Elias MossialosKonstantina Davaki
Dec 21, 2006·The International Journal of Health Planning and Management·Neelam Sekhri, William Savedoff
Apr 9, 2009·Health Economics·Erik SchokkaertCarine Van de Voorde
Apr 16, 2015·Health Economics, Policy, and Law·Tamara Hervey
Jun 4, 2005·International Journal of Health Services : Planning, Administration, Evaluation·Meri Tuulikki Koivusalo
May 17, 2013·Scandinavian Journal of Public Health·Ann Christensen, Rikke Søgaard
Jul 5, 2018·Ciência & saúde coletiva·Carlos Octávio Ocké-Reis
Jul 10, 2004·International Journal of Health Services : Planning, Administration, Evaluation·Kevin J Woods
Jan 27, 2019·International Journal of Health Services : Planning, Administration, Evaluation·Alexandre Morais NunesAdalberto Campos Fernandes
Nov 29, 2005·Applied Health Economics and Health Policy·Dimitris NiakasLycurgus Liaropoulos
Aug 16, 2018·The International Journal of Health Planning and Management·Alexandre Morais Nunes, Diogo Cunha Ferreira
Jul 19, 2008·Health Economics, Policy, and Law·Sarah Thomson, Elias Mossialos
Aug 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Percivil M Carrera, John Fp Bridges
May 4, 2018·Science and Engineering Ethics·Teresa Leonardo AlvesBarbara Mintzes
Sep 27, 2019·The Milbank Quarterly·Cyril Benoît, Gaël Coron
Dec 4, 2019·The International Journal of Health Planning and Management·Aida Isabel Tavares
Feb 23, 2021·The Cochrane Database of Systematic Reviews·Nkengafac Villyen MotazeCharles S Wiysonge
Sep 10, 2020·Social Science & Medicine·Hansoo Ko
Mar 24, 2021·Health Economics, Policy, and Law·Linn KullbergUlrika Winblad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.